FDA Approves Phesgo as Injection Treatment for HER2-positive Breast Cancers
News
The U.S. Food and Drug Administration (FDA) has approved Phesgo, an under-the-skin injection of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, as a faster and more convenient alternative to treat people with ... Read more